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Abstract 
Until recently, the specific neurological effects of Posttraumatic Stress Disorder (PTSD) on the brain were 
not well supported in the literature.  It has been found that the limbic system is intimately involved in this 
disorder.  Specifically, the hippocampus and the amygdala play a crucial role in the emotional memories 
in Posttraumatic Stress Disorder.  Treatment for PTSD that addresses the limbic system has been shown 
to be highly effective in studies.  Prolonged Exposure Therapy is treatment modality that activates the 
limbic system in order to reduce symptoms of PTSD.  Counselors working with clients diagnosed with 
PTSD can conceptualize this disorder in a different way that demonstrates the neurobiological 
underpinnings that further supports the use of evidence-based treatment—prolonged exposure—to not 
only reduce symptoms of PTSD, but also to change the structure of the brain of these individuals.  
Counselors improved view of the neurobiological basis of PTSD will improve their case 
conceptualizations of their clients. 
 
Post-Traumatic Stress Disorder (PTSD) is classified as an anxiety disorder that 
occurs after a person’s exposure to a traumatic, terrifying event in which “grave physical 
harm” happened or was in jeopardy of happening (APA, 2004).  Traumatic events that 
may lead to PTSD include, but are not limited to, violent personal attacks, natural 
disasters, vehicle accidents, physical or sexual abuse, combat, rape and terrorist 
attacks (APA, 2004). 
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 Three main clusters of symptoms prominent in PTSD are: 1) consistently re-
experiencing traumatic memory 2) hyperarousal 3) avoidance of stimuli associated with 
trauma (Milad et al., 2009).  People who suffer from PTSD often have difficulty 
remembering facets of the traumatic event (Werner et al., 2008).  Therefore, PTSD is 
also seen as a disorder of memory (Bremner, 2001; Hayes et al., 2011).  Milad et al. 
(2009) suggest that people with PTSD suffer from  “deficient extinction learning” (p. 
1075) where the brain fails to extinguish a conditioned fear related to PTSD 
(Felmingham et al., 2007; Koenigs & Grafman, 2009; Rauch, Shin & Phelps, 2006).  
Furthermore, PTSD could be characterized as an abnormal emotional-memory (Hayes 
et al., 2011).  The prevailing brain structure associated with emotion and memory is the 
limbic system (Britton, Phan, Taylor, Fig & Liberzon, 2005), which is comprised of, in 
part, the amygdala, hippocampus and cingulate cortex.  Moreover, Rauch et al. (2006) 
supports the popular neurobiological model of PTSD that emphasizes interactions of the 
amygdala, vmPFC and the hippocampus. To gain a clearer picture, it is pertinent to 
understand the neurobiological underpinnings of PTSD (Koenigs & Grafman, 2009). 
The amygdala plays a central role in emotional processing, perceiving threats, and fear 
conditioning (Britton et al, 2005; Koenigs & Grafman, 2009; Tronel & Alberini, 2007).  
The hippocampus is involved in learning, memory, episodic memory, and environmental 
contextual clues (Koenigs et al., 2008; Werner et al., 2009).  In light of the three cluster 
symptoms of PTSD (e.g., high anxiety, memory flashback, avoidance), it is imperative to 
gain an understanding of neural circuitry and structure related to PTSD to provide 
effective treatment (Tronel & Alberini, 2007).  This paper will examine the prevailing 
neurobiological model of PTSD, as well as, effective therapeutic interventions. 
Neurobiological Model of PTSD 
Neuroimaging studies have identified abnormal functioning of the limbic and 
paralimbic systems of the brain in pathogenesis of PTSD (Britton, Phan, Taylor, Fig  & 
Liberzon, 2006); specifically, the amygdala, hippocampus, and medial frontal cortical 
regions and the dorsal anterior cingulated cortex (dACC) (Milad et al., 2009; Rauch et 
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al., 2006).  Milad et al. stress the importance of understanding this circuitry of the brain 
and how it relates to PTSD’s dysfunctional emotional-memory processing.  Several 
studies support further investigation of these regions to fully appreciate their role in 
PTSD and individual differences among people who develop this disorder (Britton et al., 
2006; Koenigs & Grafman, 2009). 
Amygdala and vmPFC 
Koenigs and Grafman (2009) provide the following conceptualization of the role 
of the amygdala in PTSD.  The amygdala plays a role in emotional regulation such as 
anxiety, fear, and stress.  The amygdala may distort emotional memory of traumatic 
events during the encoding process that may underlie etiology of PTSD (Hayes et al., 
2011). Moreover, the amygdala plays a role in fear acquisition (Milad et al., 2009) and 
Rogers et al., (2007) contends it plays a role in extinction learning of a conditioned fear.  
For example, a combat veteran exhibiting a heightened fear response to fireworks on 
the fourth of July because it is similar to sounds of war.  Therefore, the amygdala is in a 
place to centrally alter symptoms of PTSD (Smith, Abou-Khalil, & Zald, 2008). The 
amygdala also connects to the brainstem that plays a role in the executing autonomic 
responses and physiological reactions (Koenigs & Grafman 2009) that supports the role 
of the amygdala evolutionary hypothesis of the predator model of PTSD (Clinchy, 
Schulkin, Zanette, Sheriff, McGowan, & Boonstra, 2011).  The predator model of PTSD 
postulates that when an animal or human detects an anxiety/fear-provoking situation 
that it freezes, fights, or flees the situation.  During this response, connections are made 
to the lower parts of the brain where there is less conscious control by the individual and 
perhaps this is where some dysfunctional regulation may transpire (Perry, 2009) or a 
conditioned fear may become abnormal (Rogers et al. 2007).  So why do some people 
develop symptoms of PTSD while others do not? 
 One hypothesis set forth by Rogers et al. (2009) is that a smaller amygdala is 
partially responsible for the failure of fear to be extinguished in people diagnosed with 
PTSD.   This is a notable individual difference among people who diagnosed with PTSD 
and non-PTSD diagnosed people.  Their study was the first to control for chronic 
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symptoms of PTSD and reduced volume of the amygdala.  Specifically, this study 
established that a single, intense stressful episode is associated with reduced volume of 
the amygdala that is related to avoidance symptoms of PTSD as shown on the 
assessment questionnaire, CAPS (Clinician Administered Posttraumatic Stress Disorder 
Scale).  They also found a relationship between the anterior cingulate cortex (ACC) and 
the amygdala in the failure to extinguish a fear theory of PTSD.  The ACC in their study 
showed reduced gray matter density compared to not-PTSD controls. 
Another hypothesis proposed by Koenigs and Grafman (2009) contends that 
hyperactivity in the amygdala is responsible for symptoms of PTSD and supported by 
other studies (Koenigs & Grafman, 2009; Milad et al., 2009).  Koenigs and Grafman 
(2009) performed neuroimaging on veterans with PTSD that demonstrated hyperactivity 
of the amygdala.  Rauch et al. (2006) support the putative role of hyperactivity of the 
amygdala in people diagnosed with PTSD. Additionally, several studies (Britton et al., 
2005; Koenigs & Grafman, 2009; Koenigs et al., 2008) found that lower activation of the 
amygdala seemed to inoculate against symptoms of PTSD.  Perhaps this is due to the 
modulation hypothesis, which stipulates that more emotional an event, the more likely it 
will be remembered compared to neutral event due to the modifying effect of the 
amygdala (Hayes et al., 2011).  What causes this hyperactivity in the amygdala?  The 
answer lies in the medial frontal cortical area. 
Medial Frontal Cortical Region 
 The ventral medial frontal cortex (vmPFC) is connected to the amygdala via a 
dense array of neuronal axons that mediates activity of the amygdala (Koenigs & 
Grafman, 2009).  Britton et al. (2005) found a hypoactive vmPFC was related to a 
hyperactive amygdala.  This study supports the inhibitory function of the vmPFC on the 
amygdala. This neural pathway communicates bidirectionally and it is not clear why the 
vmPFC cannot appropriately modulate the amygdala in relation to people with 
symptoms of PTSD (Koenigs & Grafman, 2009).  Perry (2009) theorizes that that the 
emotional memories are being stored in a lower part of the brain where people have 
less conscious control of emotional memories.  Therefore, if there are salient reminders 
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similar to the traumatic event in people with PTSD, there may be an uncontrollable 
emotional response due to the role of the amygdala to alert the body if danger is 
present (Perry, 2009).  What if there is damage to the amygdala or vmPFC? Is 
someone just as susceptible to symptoms of PTSD with damage to this area?  If not this 
would seemingly discount the “overactivity” theory of the amygdala. 
 Koenigs et al., (2008) analyzed focal lesions of the brains of combat veterans in 
the vmPFC, amygdala, and hippocampal regions of the limbic system to ascertain any 
reduction of symptoms or diagnosis of PTSD.  Koenigs et al. (2008) found that lesions 
in either the amygdala or vmPFC reduced prevalence of PTSD in combat veterans.  
The reduced occurrence of PTSD in veterans was not due to the absence of symptoms, 
rather due to a reduction of symptom intensity.  However, a damaged hippocampus did 
not affect whether or not PTSD developed in combat war veterans.  Koenigs et al. 
suggest that based on these findings the overactive amygdala is a critical component in 
the development of PTSD in people.  Moreover, Smith Abou-Khalil and Zald (2008) 
state that overactivity in the right amygdala is responsible for symptoms of PTSD.  
There could be unilateralized expression of symptoms of PTSD in the right amygdala.  
They support this hypothesis with a case study of a patient with a removed left 
amygdala that underwent a traumatic experience (hit by a car) and still suffered 
symptoms of PTSD.  However, a limitation of this case study was that the left amygdala 
was removed early in life because of a seizure disorder and the right amygdala may 
have adapted certain functions of the left amygdala over the years.   
Hippocampus    
The hippocampus is crucial in a person’s learning and memory (Bremner, 2001).  
The hippocampus encodes associative stimuli; it pairs two stimuli together in a person’s 
memory (Werner et al.,2009).  Based on Koenigs et al. (2008) study that a damaged 
hippocampus is not involved in reducing symptoms of PTSD, does the hippocampus 
serve a significant role in people with PTSD?  Several studies have elucidated the role 
of the hippocampus in the development of PTSD.  Bremner (2001) contends that 
damage to the hippocampus due to decreased dendritic branching and neuronal loss 
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can lead to increased probability of developing PTSD. He suggests that high stress 
levels during a traumatic event can release glucocorticoids that have been found to 
adversely affect the formation of new memories.   Bremner (2001) found that sixty-nine 
percent of patients could be correctly diagnosed with PTSD based solely on analyzing 
hippocampal volume.   
Werner et al. (2009) analyzed hippocampal functioning via fMRI in patients with 
PTSD during an associative learning task.  The hippocampus is important for encoding 
associative stimuli; they hypothesized that patients with PTSD would show a deficit in 
learning compared to non-PTSD control.  Overall, they found that patients with PTSD 
showed less activation in the hippocampus than Non-PTSD controls, but no differences 
in performance on memory as previous research suggests.  Perhaps this was due to the 
small number of subjects (n=12) that did not allow appropriate statistical analysis.  
Therefore, this study suggests that hippocampal activation does not play a role in PTSD 
like with the amygdala.  How does the overall hippocampal volume affect symptoms of 
PTSD in individuals? 
 Another study conducted by Felmingham et al. (2009) looked at the role of the 
hippocampus in subjects with PTSD.  They found that reduced right hippocampal 
volume is associated PTSD patients.  They controlled for depression since it has been 
found to correlate with reduced right hippocampal volume.  Moreover, a reduction in 
volumes in parietotemporal and frontal lobes associated with subjects diagnosed with 
chronic PTSD.  Felmingham et al. also examined time since a trauma and right 
hippocampal volume and their evidence is alarming.  Their study suggests that as time 
passes since a traumatic event and symptoms of PTSD increase, volume decreases in 
the right hippocampus.  This study is the first to report this negative and alarming 
relationship between persistent symptoms of PTSD and hippocampal volume.  They 
suggest that there is, perhaps, neuronal plasticity in the hippocampus related to 
environmental stressors.  They reason that this may be related to glucocorticoids 
causing cell atrophy or inhibition of neurogenesis that impacts overall volume of the 
hippocampus.  This study supports the view that reduced hippocampal volume 
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predisposes people to PTSD and increases the duration because of the lack of 
neurological structure to triumph over symptoms of PTSD.  Reduced hippocampal 
volume is another important individual difference that is associated with individuals with 
PTSD.  They also suggest that people with PTSD are not as able to engage in 
extinction-learning in order to break the PTSD associative learning of traumatic events 
with triggers as non-PTSD diagnosed people.  
 Hayes et al. (2010) examined hippocampal activity related to combat-related 
PTSD.  They found that reduced activity of the hippocampus was associated with high 
arousal symptoms of PTSD.  This suggests that under high stress and arousal, the 
hippocampal activity is reduced.  The hippocampus functions best under moderate 
levels of stress (Hayes et al., 2009). They reason that during this reduced activity, 
details of the traumatic memory are lost and only “gists” are recalled.  They also 
suggest that glucocorticoids may play a role to reduce hippocampal activity.  Thus, the 
hippocampus seems vulnerable to high levels of stress that seem to have deleterious 
effects on its memory functioning Vermetten, Vythilingam, Southwick, Charney and 
Bremner, (2003).  With neural plasticity, can the reduction of glucocorticoids in the 
hippocampus increase its volume and reduce symptoms of PTSD? 
 Vermetten, et al., (2003) conducted a study that demonstrated a 4.6% increase is 
hippocampal volume with medication, paroxetine following a nine to twelve month 
regimen.  This was the first study to demonstrate a reversal of volume in the 
hippocampus due to environmentally stress induced PTSD.  However, symptoms of 
PTSD were not reduced but declarative memory was improved with PTSD subjects.  
This improvement in declarative memory may be more beneficial in reducing symptoms 
of PTSD with psychological treatments (Vermetten et al., 2003).  Tronel and Alberini 
(2007) support the use of pharmacological treatment and psychological treatment to 
treat PTSD.  They found that pharmacological treatments targeting the neurotoxic 
effects of glucocorticoids would allow for neurogenesis among structures in the limbic 
system.  This regeneration will possibly allow for quicker psychological therapeutic 
interventions to reduce symptoms of PTSD (Tronel & Alberini, 2007). 
Counseling and Wellness: A Professional Counseling Journal                                                                    81 
2011 Volume 2 
 
 Overall, neurobiological model of PTSD suggests dysfunctions and abnormalities 
of specific structures in the limbic lobe.  The amygdala is overactive due to the lack of 
inhibitory control of the vmPFC via dense neural pathways of between these two 
structures.  Reduced volume of the hippocampus plays a role in symptoms of PTSD.  
Studies have suggested that this may be due to stress hormones—glucocorticoids—
that cause neural atrophy and inhibit neurogenesis, thereby, reducing hippocampal 
volume.  These individual differences (overactive amygdala, smaller hippocampus) play 
an important role in who may exhibit symptoms of PTSD. 
Psychological Treatments of PTSD 
Based on the neurobiological model of PTSD, effective treatment of PTSD needs 
to incorporate the extinction of fear learning (Felmingham et al., 2007) and help patients 
cope with distorted memories of the traumatic event (Hayes et al., 2011). Tronel and 
Alberini (2007) suggest that PE follows the neurobiological model by enhancing the 
extinction of the previously conditioned fear.  Milad et al. (2009) suggest that activation 
of amygdala, vmPFC, and hippocampus are necessary to extinguish a conditioned fear 
because it must first be accessed by the same system that initiated and then use 
counter-conditioning (relaxation) to, in effect, inhibit the old response.  In Prolonged 
Exposure therapy (PE), clients do activate this system by eliciting the fear and pairing it 
with a non-aversive stimuli (i.e. relaxation, deep breathing, etc.). 
Prolonged Exposure therapy (PE) was one of the first techniques to gain 
acceptance in literature as being an evidenced-based treatment of PTSD (Cukor, 
Olden, Lee, & Difede, 2010).  Developed by Edna Foa, PE is considered the gold 
standard for cognitive behavioral therapy for treatment of PTSD (Cukor et al., 2010). PE 
is grounded in learning theory (Cukor et al., 2010).  It is based on the notion that people 
with PTSD have problems with ‘extinction’ as it relates to memories of the traumatic 
event (Cukor et al., 2010).  There is some debate on this issue.  Rauch, Foa, Furr and 
Filip (2004) contend that a new trauma memory is developed to inhibit activation of the 
old fear structure associated with the current symptoms of PTSD.  Nevertheless, PE  
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emphasizes various learning mechanisms associated with learning theory as well as 
addressing memory of the traumatic event.  
An individual’s response to trauma with PTSD does not decrease appropriately 
even when there is no longer a danger present (Cukor et al., 2010).  This association 
between the memory of the crisis event and signal of danger is still very prevalent and 
pathological within the individual with PTSD (Rauch et al., 2004).  This association has 
not been adequately diminished (Rauch et al., 2004).  Therefore, PE attempts to 
diminish or inhibit this association using a variety of exposure methods:  imaginal, or in 
vivo (Foa, Keane, Friedman & Cohen, 2009).   “By facilitating habituation to the 
[traumatic] memory, decreasing avoidance, and eliminating associations of danger” (p. 
83) a client can begin to extinguish their anxious responses (Cukor et al, 2010).  Rauch 
et al. (2004) hold that new associations developed temporally as safety cues in the 
therapeutic environment to establish an inhibitory response of the pathological fear 
associated with the PTSD symptomatology  (Rauch et al., 2004). 
Initially PE treatment begins with clients developing an ‘anxiety hierarchy’ (Foa et 
al., 2009). Subjective Units of Distress (SUD) is a common approach to developing a 
fear (anxiety) hierarchy (Foa et al., 2009). Imaginal (imagery) exposure and in vivo are 
techniques used in PE that incorporate Subjective Units of Distress. 
 Imaginal technique begins with a client telling and retelling of the traumatic 
experience (Foa et al., 2009). A client addresses her/his traumatic memories by closing 
her/his eyes to increase the vividness and experiential nature while recounting the event 
(Foa et al., 2009).  This retelling of the memory happens repeatedly during the time 
frame of multiple sessions (Cukor et al, 2010).  Foa et al., (2009) state the client needs 
to tell the story using present tense verbs and focus on the shocking feelings of the 
trauma.  The traumatic memories need to be processed in a rich, contextualized 
manner that addresses the “sensations, thoughts, beliefs, and especially the feelings” 
(Foa et al., 2009, p. 120).  By previously scaling the SUD, the therapist can monitor the 
client’s level of distress and progress throughout therapy, (Foa et al., 2009).  Milad et al. 
(2009) proposed that activation of a fear network is needed in order for symptoms of 
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PTSD to be changed and reduced in therapy.  Rauch, Foa, Furr, Filip (2004) found that 
high anxiety in early sessions of imaginal exposure successfully activated the fear 
structure related to the memory of trauma.  Moreover, Rauch et al. (2004) found a 
significant reduction of anxiety from the first session to the sixth session, which 
suggests “a new trauma memory structure was formed that no longer contains the 
pathological associations that underlie anxious activation during imagery” (p. 464).  The 
goal is to extinguish the conditioned reactions by providing a safe environment in 
therapy (Foa et al., 2009).  Foa et al, (2009) contend that there is general consensus 
that non-reinforced exposure will lead to a reduction of anxious feelings that will enable 
a client to combat maladaptive cognitions (Foa et al, 2009). 
What imaginal and in vivo techniques have in common is the exposure to 
“frightening yet realistically safe stimuli” (p. 143) that proceeds until the client’s anxiety 
level is reduced (Foa et al., 2009).  Most exposure-based treatments incorporate some 
form of relaxation training such as deep breathing or progressive muscle relaxation (Foa 
et al., 2009). 
Clients undergoing PE for treatment of PTSD will fare better than 86% of other 
people treated with supportive counseling or comparable unstructured dialogue in 
counseling (Powers et al., 2010). These benefits are seen as “dramatic and enduring” 
(Powers et al., 2010). Considering the large effect size (g=1.06) for PE, it should be 
considered as the “treatment-of-choice” for therapists treating PTSD (Powers et al., 
2010).   
If there are abnormalities in the brain of someone who has PTSD, will there be 
changes in the brain structure of someone who has undergone Prolonged Exposure 
Treatment for PTSD?  Essentially, can the brain rewire itself?  Felmingham et al. (2007) 
conducted a study to answer the aforementioned question.  They performed MRI’s on 
subjects before and after an exposure-based treatment (i.e., Prolonged Exposure).  
Their study provides the first neuroimaging data of post-treatment PTSD subjects that 
suggests the brain does change after undergoing therapy.  Specifically, their study 
suggests an increase in rACC (vmPFC) and reduced activity of the amygdala.  
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Remarkably, an increase of vmPFC and reduced activation of the amygdala is the 
opposite of what is found in people diagnosed with PTSD.  Not only does this suggest 
that PE can reduce symptoms of PTSD, but it can alter neural pathways and activation 
sites in the brain.  Essentially, the brains of post-treatment PTSD subjects look more 
like the brains controls of the previously mentioned subjects.  Limitations of this study 
are the small sample size.  Further investigation of the neural plasticity related to post-
treatment subjects with PTSD is warranted.  However, this study supports the prevailing 
neurobiological model of PTSD and how effective treatment that is in accord with this 
model can guide the practice of the clinician to provide effective treatment to ameliorate 
potentially debilitating symptoms of this disorder and change neural pathways of the 
brain. 
Conclusion 
 PTSD is disorder affecting a person’s emotional memories of a traumatic event.  
Three clusters of symptoms of people diagnosed with PTSD are: 1) continual re-
experiencing the trauma, 2) hyperarousal, 3) avoidance of stimuli related to traumatic 
event.  These symptoms can cause significant psychological distress and impact 
functioning of the brain.  The neurobiological model of PTSD directs attention to the 
limbic system where certain abnormalities are apparent.  Increased activation of the 
amygdala coupled with a hypoactive vmPFC seems to play a role in failure to extinguish 
a condition fear.  Moreover, based on neuroimaging, reduced hippocampal size is 
evidenced in people with PTSD that may be the result of an increase of 
glucocorticoids—stress hormone—that may inhibit neruogenesis or cause neural 
atrophy that affects memory functions.  Prolonged Exposure is an effective treatment of 
PTSD that directly helps clients cope with distorted memories and thoughts, conditioned 
fear, and other emotions related to the traumatic event.  Moreover, there is burgeoning 
evidence of the neural plasticity of the brain for post-treatment patients of PTSD with 
Prolonged Exposure therapy that suggests neural and structural changes in the brain.  
Evidence suggests that counselors incorporating PE in the treatment of PTSD with their 
clients actually make structural changes in the brains of these clients that could perhaps 
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inoculate them against further development of symptoms of PTSD in the future.  In light 
of this evidence, counselors’ case conceptualization of PTSD is improved because it 
may no longer be seen as a client choosing to ruminate about a traumatic event, but a 
structural abnormality in the brain that a client cannot control.  A counselor providing 
effective Prolonged Exposure therapy can help a client regain control of their thoughts 
and emotions by helping them make structural changes in their brain.  Perhaps in the 
future, neuroimaging of the amygdala, vmPFC, and hippocampus can be used as a 
diagnostic tool for clinicians and doctors working with people suffering from PTSD. 
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